These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34126574)

  • 21. Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents.
    Yang J; Zhang P; Hu Y; Liu T; Sun J; Wang X
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):651-656. PubMed ID: 30746966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease.
    Zhang C; Yang K; Yu S; Su J; Yuan S; Han J; Chen Y; Gu J; Zhou T; Bai R; Xie Y
    Eur J Med Chem; 2019 Oct; 180():367-382. PubMed ID: 31325784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors.
    Morales-Camilo N; Salas CO; Sanhueza C; Espinosa-Bustos C; Sepúlveda-Boza S; Reyes-Parada M; Gonzalez-Nilo F; Caroli-Rezende M; Fierro A
    Chem Biol Drug Des; 2015 Jun; 85(6):685-95. PubMed ID: 25346162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
    Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y
    Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Zhang P; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Oct; 180():238-252. PubMed ID: 31310916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
    Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
    He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
    Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
    Yang HL; Cai P; Liu QH; Yang XL; Li F; Wang J; Wu JJ; Wang XB; Kong LY
    Eur J Med Chem; 2017 Sep; 138():715-728. PubMed ID: 28728104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
    Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
    Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Privileged Pharmacophore of FDA Approved Drugs in Combination with Chalcone Framework: A New Hope for Alzheimer's Treatment.
    Mathew B
    Comb Chem High Throughput Screen; 2020; 23(9):842-846. PubMed ID: 32723232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity.
    Jiang X; Guo J; Lv Y; Yao C; Zhang C; Mi Z; Shi Y; Gu J; Zhou T; Bai R; Xie Y
    Bioorg Med Chem; 2020 Jun; 28(12):115550. PubMed ID: 32503694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
    Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
    Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
    Fonseca A; Reis J; Silva T; Matos MJ; Bagetta D; Ortuso F; Alcaro S; Uriarte E; Borges F
    J Med Chem; 2017 Aug; 60(16):7206-7212. PubMed ID: 28753307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease.
    Tao D; Wang Y; Bao XQ; Yang BB; Gao F; Wang L; Zhang D; Li L
    Eur J Med Chem; 2019 Jul; 173():203-212. PubMed ID: 31005056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
    Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F
    Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
    Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
    Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of potential anti-AD hybrids with monoamine oxidase B inhibitory and iron-chelating effects.
    Guo J; Mi Z; Jiang X; Zhang C; Guo Z; Li L; Gu J; Zhou T; Bai R; Xie Y
    Bioorg Chem; 2021 Mar; 108():104564. PubMed ID: 33353806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multitarget 2'-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities.
    Kamecki F; Knez D; Carvalho D; Marcucci C; Rademacher M; Higgs J; Žakelj S; Marcos A; de Tezanos Pinto F; Abin-Carriquiry JA; Gobec S; Colettis N; Marder M
    Neuropharmacology; 2021 Dec; 201():108837. PubMed ID: 34653442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
    Hitge R; Smit S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.
    Pachón-Angona I; Refouvelet B; Andrýs R; Martin H; Luzet V; Iriepa I; Moraleda I; Diez-Iriepa D; Oset-Gasque MJ; Marco-Contelles J; Musilek K; Ismaili L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):479-489. PubMed ID: 30712420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.